A forum for researchers, students and applicants in the field of cyclodextrin technology
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of
Approval based on results from three pivotal trials showing treatment with ZULRESSO provided significant and rapid reduction of depressive symptoms
Could excipients mask a bioactive effect? The team of López-Nicolás J.M. (University of Murcia, Spain) has recently published a curious
A group of researchers employed by different subsidiaries of Janssen Research & Development, Scripps Research Institute, Department of Epidemiology, as well
The 4th International Summer School on Cyclodextrins welcomes graduate students, Ph.D students and researchers interested in all the aspects of
Sepsis is an often deadly complication of infection in which systemic inflammation damages the vasculature, leading to tissue hypoperfusion and
The open-access journal Molecules with Bernard Martel as guest editor has started to publish the papers in the special issue
In our previous post we talked about the “classical” usage of cyclodextrins in veterinary medicine. Now let’s see some non-usual
It is well known, that cyclodextrins have many different applications. Can they be used in veterinary medicine? Well, yes and
As of January 1st, 2019, besides the long valid (August 1st, 2012) monograph in USP NF for Betadex Sulfobutyl Ether
